OK‐432 and lymphatic malformations in children: the Starship Children's Hospital experience

Background:  Surgery has previously been the mainstay of treatment for lymphatic malformations but has attendant problems of marked scarring, high chance of recurrence and potential nerve damage. Alternative management for these lesions involves the intralesional injection of OK‐432. The present paper reviews OK‐432 use in lymphatic malformations in children.

[1]  M. Höllwarth,et al.  OK-432 therapy of lymphangiomas in children , 1996, European Journal of Pediatrics.

[2]  A. Pierro,et al.  Is intralesional injection of OK-432 effective in the treatment of lymphangioma in children? , 2003, Surgery.

[3]  Richard J. H. Smith,et al.  New Treatment Options for Lymphangioma in Infants and Children , 2002, The Annals of otology, rhinology, and laryngology.

[4]  Yutaka Sato,et al.  Treatment of lymphangiomas with OK-432 (Picibanil) sclerotherapy: a prospective multi-institutional trial. , 2002, Archives of otolaryngology--head & neck surgery.

[5]  T. Kennedy,et al.  Cystic Hygroma/Lymphangioma: A Rational Approach to Management , 2001, The Laryngoscope.

[6]  A. Alqahtani,et al.  25 years' experience with lymphangiomas in children. , 1999, Journal of pediatric surgery.

[7]  E. Deguchi,et al.  OK-432 therapy for lymphangioma in children: why and how does it work? , 1996, Journal of pediatric surgery.

[8]  E. Deguchi,et al.  OK-432 therapy in 64 patients with lymphangioma. , 1994, Journal of pediatric surgery.

[9]  E. Deguchi,et al.  OK-432 therapy for unresectable lymphangiomas in children. , 1991, Journal of pediatric surgery.

[10]  S. Ogita,et al.  Treatment of cystic hygroma in children with special reference to OK-432 therapy. , 2008, Zeitschrift fur Kinderchirurgie : organ der Deutschen, der Schweizerischen und der Osterreichischen Gesellschaft fur Kinderchirurgie = Surgery in infancy and childhood.